Gut
Simvastatin in the prevention of recurrent pancreatitis: a triple-blinded randomised clinical trial (the SIMBA trial).
Lucía Guilabert, Karina Cárdenas-Jaén, Alicia Vaillo-Rocamora, María Lourdes Ruiz-Rebollo, Federico Bolado-Concejo, Emma Martínez-Moneo, Robin Rivera-Irigoin, Rosa Martin-Mateos, Guillermo García-Rayado, Antonio López-Serrano, Eva Martí-Marqués, Juan Armando Rodríguez-Oballe, María Francisco-González, Manuel A Jiménez-Moreno, Pablo Cañamares-Orbís
Published: 202610.1136/gutjnl-2025-337154
Abstract
BACKGROUND: Recurrent acute pancreatitis (RAP) or acute-on-chronic flares in chronic pancreatitis (CP) have limited preventive options beyond addressing the underlying aetiology. Statins, due to their anti-inflammatory properties, have been proposed…
Preview only. Read the full abstract at the source